Rezolve AI is trading at $2.21, down 5.06%, as its wider-than-expected net loss overshadowed first-half revenue growth.

  • Reported a $139.5 million net loss, or $0.35 per share, despite $130.8 million first-half revenue; the loss exceeded expectations.
  • Operating expenses and integration costs increased substantially, while management reaffirmed approximately $360 million 2026 revenue guidance and its $500 million ARR target.
  • Roth Capital lowered its price target to $6.50 from $9.50 on September 2 while retaining a positive rating.